Department of Respiratory Medicine, Tenri Hospital, Japan.
Intern Med. 2023 Nov 15;62(22):3291-3298. doi: 10.2169/internalmedicine.0836-22. Epub 2023 Mar 15.
Objective Chronic pulmonary aspergillosis (CPA) is an important complication of nontuberculous mycobacterial pulmonary disease (NTM-PD). However, its diagnosis is challenging, as both CPA and NTM-PD present as chronic cavitary disease. The present study evaluated the impact of CPA on the survival of patients with NTM-PD and revealed the key computed tomography findings for a prompt diagnosis. Methods We retrospectively reviewed patients newly diagnosed with NTM-PD in Tenri Hospital (Tenri City, Nara Prefecture, Japan) between January 2009 and March 2018; the patients were followed up until May 2021. Clinical and radiological characteristics were assessed, and patients with CPA were identified. Results A total of 611 patients were diagnosed with NTM-PD. Among them, 38 (6.2%), 102 (17%), and 471 (77%) patients were diagnosed with NTM-PD with CPA, cavitary NTM-PD without CPA, and non-cavitary NTM-PD without CPA, respectively. The 5-year survival rate of the NTM-PD with CPA group (42.8%; 95% confidence interval: 28.7-64.0%) was lower than that of the cavitary NTM-PD without CPA group (74.4%; 95% confidence interval: 65.4-84.6%). A multivariate analysis revealed that fungal balls and cavities with adjacent extrapleural fat were significant predictive factors for NTM-PD with CPA. Conclusion NTM-PD with CPA patients exhibited a worse prognosis than cavitary NTM-PD without CPA patients. Therefore, an unerring diagnosis of CPA is essential for managing patients with NTM-PD. Computed tomography findings, such as fungal balls and cavities with adjacent extrapleural fat, may be valuable diagnostic clues when CPA is suspected in patients with NTM-PD.
慢性肺曲霉病(CPA)是非结核分枝杆菌肺病(NTM-PD)的重要并发症。然而,其诊断具有挑战性,因为 CPA 和 NTM-PD 均表现为慢性空洞性疾病。本研究评估了 CPA 对 NTM-PD 患者生存的影响,并揭示了有助于快速诊断的关键 CT 表现。
我们回顾性分析了 2009 年 1 月至 2018 年 3 月期间在日本奈良县天理市 Tenri 医院新诊断为 NTM-PD 的患者;对患者进行随访,随访至 2021 年 5 月。评估了临床和影像学特征,并确定了 CPA 患者。
共诊断出 611 例 NTM-PD 患者。其中,38 例(6.2%)、102 例(17%)和 471 例(77%)患者分别诊断为有 CPA 的 NTM-PD、无 CPA 的空洞性 NTM-PD 和无 CPA 的非空洞性 NTM-PD。有 CPA 的 NTM-PD 组(42.8%;95%置信区间:28.7-64.0%)的 5 年生存率低于无 CPA 的空洞性 NTM-PD 组(74.4%;95%置信区间:65.4-84.6%)。多变量分析显示,真菌球和毗邻胸膜外脂肪的空洞是有 CPA 的 NTM-PD 的显著预测因素。
有 CPA 的 NTM-PD 患者的预后较无 CPA 的空洞性 NTM-PD 患者差。因此,准确诊断 CPA 对于 NTM-PD 患者的治疗至关重要。当怀疑 NTM-PD 患者存在 CPA 时,CT 表现(如真菌球和毗邻胸膜外脂肪的空洞)可能是有价值的诊断线索。